Betta Pharmaceuticals Co., Ltd.

SZSE:300558 Rapporto sulle azioni

Cap. di mercato: CN¥19.3b

Betta Pharmaceuticals Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Lieming Ding

Amministratore delegato

CN¥2.9m

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO11.3yrs
Proprietà del CEO0.2%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazione5yrs

Aggiornamenti recenti sulla gestione

Recent updates

We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Nov 04
We Think That There Are Some Issues For Betta Pharmaceuticals (SZSE:300558) Beyond Its Promising Earnings

Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Sep 30
Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Still On The Mark Following 29% Share Price Bounce

Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Aug 07
Results: Betta Pharmaceuticals Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

Jul 30
Unpleasant Surprises Could Be In Store For Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) Shares

These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Jul 05
These 4 Measures Indicate That Betta Pharmaceuticals (SZSE:300558) Is Using Debt Reasonably Well

Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Apr 26
Betta Pharmaceuticals' (SZSE:300558) Earnings Are Weaker Than They Seem

Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

Apr 23
Earnings Miss: Betta Pharmaceuticals Co., Ltd. Missed EPS By 6.1% And Analysts Are Revising Their Forecasts

What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

Apr 16
What Betta Pharmaceuticals Co., Ltd.'s (SZSE:300558) P/E Is Not Telling You

AMMINISTRATORE DELEGATO

Lieming Ding (61 yo)

11.3yrs

Mandato

CN¥2,900,800

Compensazione

Dr. Lieming Ding founded Betta Pharmaceuticals Co., Ltd.(also known as Zhejiang BetaPharma Co., Ltd) in 2002 and serves as its Chairman. Dr. Ding has been Chief Executive Officer and General Manager of Bet...

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Lieming Ding
Founderno dataCN¥2.90m0.24%
CN¥ 45.4m
Jianxun Fan
VP, CFO & Directorno dataCN¥1.46m0.031%
CN¥ 6.0m
Jiang Wan
Senior VP5yrsCN¥2.55m0.025%
CN¥ 4.8m
Jia Tong
Directorno dataCN¥1.46m0.039%
CN¥ 7.6m
Wei Wang
Independent Director5yrsCN¥120.00kNessun dato
Cai Jiangnan
Independent Director5yrsCN¥120.00kNessun dato
Yangnan Zhang
Chairman of the Supervisory Board & Senior Director of Project Declaration5yrsCN¥870.70kNessun dato
Zhihua Yu
Director5yrsNessun datoNessun dato
Tian Xu
Director2.1yrsNessun datoNessun dato
Fei Wu
Supervisorno dataCN¥860.20kNessun dato
Jiajia Xiao
Independent Director2.1yrsCN¥120.00kNessun dato
Rong Wang
Shareholder Supervisor1.9yrsNessun datoNessun dato

5.0yrs

Durata media

56.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 300558 sono considerati esperti (durata media dell'incarico 5 anni).